Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Unknown 3Not yet recruiting 2Recruiting 1

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Breast Neoplasms 468Neoplasms 332Colorectal Neoplasms 235Carcinoma, Non-Small-Cell Lung 235Lung Neoplasms 200Prostatic Neoplasms 182Carcinoma, Hepatocellular 175Stomach Neoplasms 138Pancreatic Neoplasms 126Leukemia, Myeloid, Acute 115Uterine Cervical Neoplasms 111Rectal Neoplasms 103Multiple Myeloma 94Recurrence 89Squamous Cell Carcinoma of Head and Neck 84Head and Neck Neoplasms 80Ovarian Neoplasms 78Neoplasm Metastasis 77Brain Neoplasms 71Colonic Neoplasms 68Glioblastoma 67Esophageal Neoplasms 66Triple Negative Breast Neoplasms 64Endometrial Neoplasms 61Small Cell Lung Carcinoma 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Motor Activity 54Hematologic Neoplasms 54Disease 54Glioma 48

Interventions

nabiximols 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Advanced Malignant Solid Tumor × Clear all
NCT07459920 2026-03-10

CAPTURE

National Cancer Institute, Naples

Phase 2 Not yet recruiting
156 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

NCT06713148 2025-02-06

Study on the Safety and Efficacy of Intratumoral Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors

Fudan University

Phase EARLY_PHASE1 Not yet recruiting
42 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡